Literature DB >> 34749034

Case series of chronic occupational lead exposure in shooting ranges.

Gabija Laubner1, Indrė Stražnickaitė2.   

Abstract

INTRODUCTION: Despite existing occupational lead exposure prevention regulations, Lithuanian shooting range workers still complain of chronic lead poisoning related symptoms. This indicates a poor understanding of occupational safety when working in lead-polluted environments. CASE
PRESENTATION: 20 men, whose age ranged from 32 to 57 (mean 41.8 ± 10 years), were consulted at the Toxicology Centre at the Republican Vilnius university hospital in Vilnius, Lithuania in the 2016-2019 year period. All of the patients were working as shooting instructors, with their work experience varying from 2 to 30 years. Clinical examination showed blood lead levels ranging from 5.64 μg/dL to 45.8 μg/dL (norm for occupational exposure - <40 μg/dL). Main symptoms were fatigue (12 patients out of 20), dizziness (5/20), arthralgia (5/20). Other symptoms included impaired memory (3/20), nausea (3/20), sleep disorders (3/20), metallic or sweet taste (3/20), dermatological disorders (3/20), coxarthrosis (2/20), balance disorders (2/20), paresthesia (2/20), abdominal pain (2/20) and others. 4 patients were asymptomatic. DISCUSSION: Shooting range employees are highly vulnerable to daily lead exposure. Even low constant elevated blood lead concentrations can have significant toxic effects over time.
Copyright © 2021 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Lead poisoning; Occupational poisoning; Pb

Mesh:

Substances:

Year:  2021        PMID: 34749034     DOI: 10.1016/j.jtemb.2021.126886

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  1 in total

1.  Assessment of the Effectiveness of Ventilation Controls in Managing Airborne and Surface Lead Levels at a Newly Commissioned Indoor Shooting Range.

Authors:  Robert Alcock; Magdalena Wajrak; Jacques Oosthuizen
Journal:  Int J Environ Res Public Health       Date:  2022-09-16       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.